Abstract
This study aimed to identify the direct costs of hospitalizations due to three smoking-related groups of diseases - cancer and circulatory and respiratory diseases - in Brazil's Unified National Health System (SUS) in 2005. For cancer, the cost of chemotherapy was also included. The study derived cost estimates using administrative databases, relative risks, smoking prevalence, and smoking-attributable fraction. According to the estimates, smoking- attributable medical expenditures for the three disease groups amounted to R$338,692,516.02 (approximately U$185 million), accounting for 27.6% of total medical expenditures. Considering all hospitalizations and chemotherapy provided by the National Health System, tobacco-related diseases accounted for 7.7% of total medical expenditures. These costs also represented 0.9% of expenditures by federally funded public health services. This study provides a conservative estimate of smoking-related costs and suggests the need for continued research on comprehensive approaches to measure the total burden of smoking for society.
Highlights
A Organização Mundial da Saúde (OMS) estima que o tabagismo é responsável por aproximadamente [5,4] milhões de óbitos anuais
This study aimed to identify the direct costs of hospitalizations due to three smoking-related groups of diseases – cancer and circulatory and respiratory diseases – in Brazil’s Unified National Health System (SUS) in 2005
Considering all hospitalizations and chemotherapy provided by the National Health System, tobacco-related diseases accounted for 7.7% of total medical expenditures
Summary
Neste trabalho optou-se por mensurar os custos diretos atribuíveis ao tabagismo, considerando o custo do tratamento das principais doenças tabaco-relacionadas para indivíduos com mais de 35 anos em 2005. O estudo examinou os custos referentes às internações para três grupos de doença: câncer, aparelho circulatório e respiratório. No que tange às neoplasias foram também considerados os custos dos procedimentos de quimioterapia. A identificação dos grupos – câncer, aparelho circulatório e aparelho respiratório – foi realizada com base no Cancer Prevention Study II (CPS-II) 26,27,28. Como o CPS-II categoriza as patologias pela Classificação Internacional das Doenças, 9a Revisão (CID-9), neste trabalho foram compatibilizados os códigos desta revisão com a Classificação Internacional das Doenças, 10a Revisão (CID-10), segundo os critérios do Mortality Statistics Branch do CDC 29. O diagnóstico principal da internação e da quimioterapia foi definido baseando-se no código de categorias de três caracteres da CID-10 para cada uma das enfermidades dos grupos mencionados anteriormente. As doenças selecionadas para o estudo de custos são apresentadas na Tabela 1
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.